the likelihood of relapse (i.e., odds ratios) favors the Vivitrol versus treatment as usual group broken down by gender, race, age, marital status, and other characteristics.
May 10, 2018 |
Friedman et al. 2018 – Patient characteristics tested to moderate (change) the effectiveness of Vivitrol